Evidence map›Paper›PMID 39463728›Full record

ArticleRisk management and healthcare policy2024

Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD: Jordan's Perspective Based on Knowledge and Attitude Determinants.

Omar Alqudah, Hamzeh Feras Alshahwan, Jehad Feras Alsamhouri, Saif Yamin, Ahmad Kaffaf, Mohannad Alassaf, Zaid Alwarawrah

Abstract read
In one paragraph

Article in Risk management and healthcare policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Omar AlqudahDepartment of Medicine, Division of Hepatology and Gastroenterology, Jordan University Hospital and School of Medicine, The University of Jordan, Amman, Jordan.
Hamzeh Feras Alshahwan *School of Medicine, The University of Jordan, Amman, Jordan.ORCID 0009-0000-5402-8146
Jehad Feras Alsamhouri *School of Medicine, The University of Jordan, Amman, Jordan.ORCID 0000-0002-4878-7362
Saif Yamin *School of Medicine, The University of Jordan, Amman, Jordan.ORCID 0009-0001-4527-6567
Ahmad Kaffaf *School of Medicine, The University of Jordan, Amman, Jordan.ORCID 0009-0002-4795-8358
Mohannad Alassaf *School of Medicine, The University of Jordan, Amman, Jordan.
Zaid AlwarawrahSchool of Medicine, University of Mu'tah, Al-Karak, Jordan.ORCID 0000-0002-3689-4566

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The most prevalent chronic liver disease in both developed and developing nations is Metabolic dysfunction-associated Steatotic Liver Disease (MASLD). The condition increases the risk of comorbidities and liver-related morbidity and mortality. The public's awareness and medical personnel's understanding are essential in creating countermeasures to stop the disease's spread; a positive attitude is essential for early screening. This study aimed to explore the knowledge and attitudes of Jordanians living in Amman toward MASLD to determine the public's awareness and medical personnel's understanding of the disease. Materials and Methods: A cross-sectional study was conducted using an online self-administered questionnaire that included 5 items for knowledge and 8 for attitude. Demographic questions were also included to further examine how demographic factors affected knowledge and attitude. Results: Among 906 responders, (63.4%) were females, and (36.6%) were males. The majority age group was 18-30 (56.2%). Only 49.5% had previous knowledge of MASLD, (44.6%) believed they were at risk of developing it. There is a statistical significance between age, gender, educational level, and having a good knowledge of MASLD and a positive attitude towards it (p<0.05). Conclusion: Generally, Jordan's population has a fair knowledge of MASLD and a positive attitude towards it. Warranting more research into the reasons behind it, and more awareness campaigns.

Indexed as

hepatic steatosisliver healthMASLDmedical literacyMetabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLDnonalcoholic fatty liver diseasepatient educationpublic health awareness

Identifiers

PMID39463728
PMCPMC11512787

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.